Intelligence · Clinical Pipeline
Hospital Authority Pipeline
All ClinicalTrials.gov programs at Hospital Authority — phase, modality, and trial IDs.
- Programs
- 60
Quick answer
Hospital Authority has 60 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
Vitamin D3
Hospital Authority, Hong Kong
Bronchiectasis
1 trial -
Z-Brace interbody fusion device
Hospital Authority, Hong Kong
Cervical Disc Degeneration
1 trial -
conbercept
Hospital Authority, Hong Kong
Polypoidal Choroidal Vasculopathy
1 trial -
conventional dose epinephrine
Hospital Authority, Hong Kong
Croup
1 trial -
fluticasone/salmeterol, tiotropium
Hospital Authority, Hong Kong
COPD
1 trial -
gastric scintigraphy
Hospital Authority, Hong Kong
Functional Dyspepsia
1 trial -
isoniazid, rifampin, pyrazinamide
Hospital Authority, Hong Kong
Hepatitis
1 trial -
mirabegron
Hospital Authority, Hong Kong
Sjogren's Syndrome
1 trial -
moxifloxacin
Hospital Authority, Hong Kong
Intra-abdominal Infection
1 trial -
omeprazole plus amoxicillin
Hospital Authority, Hong Kong
Duodenal Ulcer
1 trial -
pegylated interferon alpha and plus ribavirin
Hospital Authority, Hong Kong
Chronic Hepatitis C
1 trial -
video capsule endoscopy
Hospital Authority, Hong Kong
Overt Obscure Gastrointestinal Bleeding
1 trial
Frequently asked questions
How many pipeline programs does Hospital Authority have?
60 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs